
Nanoquin 64.5mg Injection
Marketer
Leo Pharmaceuticals
Salt Composition
Chloroquine (64.5mg)
Overview Nanoquin 64.5mg Injection
Malarone 64.5mg Injection combats malaria parasites, preventing and treating the infection. Its mechanism involves eliminating the causative parasite, halting disease progression. Administration is strictly by a healthcare provider via injection; self-administration is prohibited. Mosquito bite prevention is crucial: apply insect repellent to exposed skin, spray repellent indoors, and wear light-colored, protective clothing after dusk. Potential side effects include weakness, nausea, vomiting, rash, and itching; gastrointestinal upset (diarrhea, abdominal pain, anorexia) may also occur. Injection site reactions (pain, swelling, redness) are possible. Persistent side effects warrant medical attention. Diabetics should report their condition, as blood sugar reduction may occur, necessitating regular monitoring. Blurred vision is a potential side effect, prompting the recommendation of regular eye exams during treatment. Long-term use may necessitate routine blood cell count monitoring. Report any unexplained bruising, bleeding, sore throat, fever, or fatigue to your physician.
Primary Ingredients of Nanoquin 64.5mg Injection
No text provided to rephrase.
Uses of Nanoquin 64.5mg Injection
Managing Malaria Infections
Major Benefits of Nanoquin 64.5mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Nanoquin 64.5mg Injection:
- Weakness
- Rash
- Headache
- Dizziness
- Vomiting
- Nausea
- Stomach pain
- Loss of appetite
- Diarrhea
How to use Nanoquin 64.5mg Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
How Nanoquin 64.5mg Injection works:
Artesunate injection, 64.5mg, combats malaria, a parasitic infection. Its mechanism involves elevating blood haem levels, a compound lethal to the malaria parasite, thereby eliminating the parasite and halting infection progression.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Nanoquin 64.5mg Injection may pose unknown risks. Physician consultation is advised.
PregnancyCONSULT YOUR DOCTOR
The use of Nanoquin 64.5mg Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the unborn child. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
Administering Nanoquin 64.5mg Injection while breastfeeding is considered safe. Research in humans indicates negligible transfer of the medication into breast milk, posing no known risk to the infant.
DrivingUNSAFE
Administering Nanoquin 64.5mg Injection may induce adverse reactions that impair driving capabilities. These reactions can include blurred vision or difficulty focusing, potentially affecting safe operation of a vehicle.
KidneyCAUTION
Administering the 64.5mg Nanoquin Injection to individuals with impaired renal function requires careful consideration. Dosage modification for Nanoquin 64.5mg Injection might be necessary. Physician consultation is advised.
LiverCAUTION
Patients with hepatic impairment should exercise caution when using Nanoquin 64.5mg Injection. Dosage modification for Nanoquin 64.5mg Injection may be necessary. Physician consultation is recommended. Routine monitoring of liver function is advisable during treatment.
What if you forget to take Nanoquin 64.5mg Injection :
NA
Facts to Know About Nanoquin 64.5mg Injection
| Label | Value |
|---|---|
| Chemical Classification | 4-Aminoquinoline analog |
| Developing Habits | No. |
| Treatment Category | Ophthalmology |
| Action class | Aminoquinoline Antimalarials |
